Karyopharm Therapeutics reported a gross margin of 96.75% and a net margin of -200.48% for the quarter ended Jun 2026. These financial ratios cover 54 quarters of results from Dec 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 94.96% | 98.44% | 99.41% | 97.01% | 97.63% | 97.29% | 94.44% | 96.51% | 96.82% | 97.47% | 95.60% | 94.23% | 96.58% | 96.65% | 95.64% | 95.67% | 97.23% | 95.20% | 95.65% | 96.75% | ||||||||||||||||||||||||||||||||||
| EBT Margin | -236.49% | -137.19% | 30.57% | -86.57% | -123.34% | -100.37% | -117.11% | -88.05% | -86.49% | -95.79% | -124.32% | -112.57% | 55.76% | -82.62% | -101.40% | -78.05% | -98.11% | -75.14% | -300.08% | -200.48% | ||||||||||||||||||||||||||||||||||
| EBIT Margin | -217.02% | -116.25% | 37.19% | -72.55% | -108.14% | -85.32% | -100.86% | -79.85% | -78.70% | -86.81% | -112.03% | -101.91% | -65.72% | -67.77% | -102.42% | -110.80% | -64.30% | -34.56% | -52.36% | -67.38% | ||||||||||||||||||||||||||||||||||
| EBITDA Margin | -217.02% | -116.25% | 37.19% | -72.55% | -108.14% | -85.32% | -100.86% | -79.85% | -78.70% | -86.81% | -112.03% | -101.91% | -65.72% | -67.77% | -102.42% | -110.80% | -64.30% | -34.56% | -52.36% | -67.38% | ||||||||||||||||||||||||||||||||||
| Operating Margin | -217.02% | -116.25% | 37.19% | -72.55% | -108.14% | -85.32% | -100.86% | -79.85% | -78.70% | -86.81% | -112.03% | -101.91% | -65.72% | -67.77% | -102.42% | -110.80% | -64.30% | -34.56% | -52.36% | -67.38% | ||||||||||||||||||||||||||||||||||
| Net Margin | -237.08% | -137.47% | 30.64% | -86.84% | -123.65% | -100.50% | -117.42% | -88.19% | -86.83% | -95.83% | -124.70% | -112.79% | 55.61% | -82.70% | -101.04% | -78.17% | -98.22% | -75.21% | -178.98% | -200.48% | ||||||||||||||||||||||||||||||||||
| FCF Margin | -246.66% | -63.57% | 20.01% | -124.35% | -88.57% | -78.60% | -79.94% | -48.87% | -68.38% | -82.01% | -55.07% | -132.58% | -89.98% | -50.16% | -84.33% | -129.88% | -49.29% | -13.30% | -34.71% | |||||||||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 3.51M | 3.92M | 4.02M | 3.99M | 3.67M | 3.86M | 4.24M | 4.03M | 3.75M | 3.39M | 3.07M | 2.91M | 3.12M | 4.07M | 4.71M | 4.75M | 4.88M | 4.48M | 4.00M | 4.02M | ||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 280.74M | 270.33M | 279.70M | 299.67M | 275.26M | 243.86M | 294.70M | 341.99M | 311.81M | 283.89M | 255.20M | 222.45M | 209.22M | 201.73M | 176.95M | 146.06M | 116.30M | 100.56M | 102.32M | 109.87M | ||||||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | -136.21M | -38.62M | -65.54M | -91.41M | -110.69M | -143.11M | -172.86M | -177.12M | -204.81M | |||||||||||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.36 | 0.44 | 0.75 | 0.78 | 0.91 | 1.02 | 0.53 | 0.43 | 0.47 | 0.51 | 0.57 | 0.63 | 0.70 | 0.74 | 0.82 | 0.97 | 1.18 | 1.42 | 1.43 | 1.36 | ||||||||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -9.81 | -5.47 | 5.91 | -5.17 | -6.80 | -5.04 | -5.76 | -5.37 | -5.11 | -5.15 | -6.09 | -5.74 | -3.14 | -2.31 | -2.79 | -3.02 | -2.17 | -1.38 | -1.41 | -1.71 | ||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.44 | 0.50 | 0.58 | 0.75 | 0.91 | 1.00 | 1.07 | 1.13 | ||||||||||||||||||||||||||||||||||||||||||||||
| Times Interest Earned | -9.81 | -5.47 | 5.91 | -5.17 | -6.80 | -5.04 | -5.76 | -5.37 | -5.11 | -5.15 | -6.09 | -5.74 | -3.14 | -2.31 | -2.79 | -3.02 | -2.17 | -1.38 | -1.41 | -1.71 | ||||||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -14.51 | -8.48 | 12.59 | -14.14 | -7.34 | -12.18 | -7.06 | -12.99 | -6.27 | -4.45 | -2.36 | -4.71 | 4.55 | -3.24 | -2.76 | -1.37 | -1.00 | -1.72 | -1.32 | -4.22 | ||||||||||||||||||||||||||||||||||
| Price to SalesP/S | 34.40 | 11.66 | 3.86 | 12.28 | 9.07 | 12.24 | 8.29 | 11.46 | 5.45 | 4.26 | 2.95 | 5.31 | 2.53 | 2.68 | 2.79 | 1.07 | 0.98 | 1.29 | 2.36 | 8.46 | ||||||||||||||||||||||||||||||||||
| Price to BookP/B | -9.35 | -3.49 | -6.11 | -7.05 | -3.09 | -3.15 | -16.71 | -9.81 | -2.87 | -1.53 | -0.73 | -1.04 | -0.82 | -0.65 | -0.46 | -0.16 | -0.16 | -0.21 | -0.27 | -0.86 | ||||||||||||||||||||||||||||||||||
| Enterprise Value | 541.60M | 235.23M | 258.46M | 380.04M | 189.06M | 294.05M | 0.41M | 182.99M | -32.09M | -54.85M | -92.00M | 27.28M | -43.94M | -29.52M | -59.22M | -53.39M | -14.43M | 11.03M | 16.74M | 217.62M | ||||||||||||||||||||||||||||||||||
| EV to EBIT | -11.04 | -5.37 | 5.50 | -10.99 | -4.41 | -9.53 | -0.01 | -5.92 | 1.08 | 1.75 | 2.43 | -0.81 | 1.56 | 1.12 | 1.89 | 1.61 | 0.59 | -0.72 | -0.94 | -9.66 | ||||||||||||||||||||||||||||||||||
| EV to EBITDA | -11.04 | -5.37 | 5.50 | -10.99 | -4.41 | -9.53 | -0.01 | -5.92 | 1.08 | 1.75 | 2.43 | -0.81 | 1.56 | 1.12 | 1.89 | 1.61 | 0.59 | -0.72 | -0.94 | -9.66 | ||||||||||||||||||||||||||||||||||
| Market Capitalization | 777.49M | 439.44M | 487.07M | 585.35M | 359.91M | 442.43M | 278.38M | 443.37M | 204.68M | 153.47M | 99.44M | 175.86M | 108.19M | 104.01M | 85.32M | 32.04M | 37.27M | 56.91M | 80.48M | 282.72M | ||||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -13.95 | -18.34 | 19.28 | -9.87 | -10.24 | -15.57 | -10.37 | -23.45 | -7.96 | -5.20 | -5.35 | -4.00 | -2.81 | -5.35 | -3.31 | -0.82 | -1.99 | -9.71 | -6.80 | |||||||||||||||||||||||||||||||||||
| EV to FCF | -9.72 | -9.82 | 10.23 | -6.41 | -5.38 | -10.35 | -0.02 | -9.68 | 1.25 | 1.86 | 4.95 | -0.62 | 1.14 | 1.52 | 2.30 | 1.37 | 0.77 | -1.88 | -1.42 | |||||||||||||||||||||||||||||||||||
| EV to CFO | -9.72 | -9.82 | 10.15 | -6.42 | -5.38 | -10.36 | -0.02 | -9.68 | 1.25 | 1.86 | 4.95 | -0.62 | 1.14 | 1.52 | 2.29 | 1.37 | 0.77 | -1.88 | -1.42 | |||||||||||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -217.02% | -116.25% | 37.19% | -72.55% | -108.14% | -85.32% | -100.86% | -79.85% | -78.70% | -86.81% | -112.03% | -101.91% | -65.72% | -67.77% | -102.42% | -110.80% | -64.30% | -34.56% | -52.36% | -67.38% | ||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -83.37% | -90.49% | -47.71% | -34.49% | -34.95% | -33.70% | -62.15% | -49.39% | -49.50% | -56.62% | -69.75% | -84.27% | -86.38% | -89.83% | -141.05% | -213.56% | -674.55% | -777.28% | -883.74% | 328.23% | ||||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 242.69% | 152.32% | 117.74% | 90.78% | 65.92% | 40.95% | 34.68% | |||||||||||||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -74.06% | -76.29% | -44.38% | -36.07% | -37.63% | -36.13% | -56.40% | -46.48% | -45.70% | -49.56% | -56.17% | -65.89% | -43.09% | -43.49% | -43.23% | -42.86% | -106.32% | -124.01% | -151.32% | -180.58% |